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Smart fluorescent probes for imaging macrophage
activity†
Antonio Fernández and Marc Vendrell*
Macrophages are multi-functional immune cells with key roles in host defense and tissue remodelling. The
broad array of macrophage functions has prompted the development of very diverse smart fluorescent
architectures, rationally designed to elicit a fluorescent signal only after target engagement. This tutorial
review covers recent advances in the design, synthesis and application of smart fluorescent probes for
imaging macrophage cellular activity, ranging from small fluorophores to peptide-based probes with
internally quenched fluorescent pairs or activity-based reactive groups.
Key learning points
1. Recent advances in chemical strategies to optimise small reactive fluorophores targeting intracellular macrophage activity.
2. The power of chemical architectures with enhanced fluorescence amplification (e.g. quenched polymers, FRET peptides) and their associated challenges.
3. Activity-based probes as a chemical strategy to fine-tune enzyme specificity.
4. Diversity-oriented fluorophores as an alternative to conventional rational design for the discovery of macrophage-specific fluorophores.
5. Perspectives and challenges of in vivo imaging and theranostic approaches for macrophage-associated disorders.
1. Introduction
1.1. The ‘grand challenge’ of developing chemical tools for
imaging cellular activity in real time: smart fluorescent probes
Optical imaging offers exceptional opportunities to visualise
and quantify multiple dynamic events in living cells with high
molecular resolution. Recent advances in the translation and
resolution power of fluorescence imaging, together with our
increasing knowledge on the development of fluorescent
probes, have opened the possibility of generating bespoke
reagents to image cellular activity in real time. Compounds
emitting fluorescence only after activation by specific signalling
molecules or proteins are ideal for this purpose, exhibiting high
signal-to-noise ratios –thus, high sensitivity – and enabling in situ
imaging without any washing steps. Such fluorescent architectures
are usually known as activatable or smart fluorophores, since
they are rationally designed to elicit a fluorescent signal only
after target engagement. The construction of smart fluorophores
is a multidisciplinary exercise that involves organic chemistry to
design suitable chemical structures with ‘off–on’ properties, and
chemical biology to validate the probes and their molecular
targets in relevant models. Smart fluorescent probes for imaging
cellular activity offer a whole range of possibilities in biological and
medical research, from the interrogation of biological processes
in vivo to the visualisation of differential patterns between healthy
and disease states with a direct application in diagnostics and
drug discovery.
Macrophages are multi-functional immune cells with key
roles in host defense and tissue remodelling, and have
been widely studied as a model for imaging cellular activity.
Imaging the activity of macrophages is not straightforward
since they exhibit relatively plastic phenotypes, with enzyme
and metabolic activity profiles depending on their micro-
environment. However, this diversification has facilitated the
development of chemical architectures to assess macrophage
activity at different levels (e.g. enzymatic activity, redox states,
phagocytosis). In this article, we will review the advances over
the last 10 years in the design, synthesis and application of
smart fluorescent probes for imaging the activity of macro-
phages. Our review specifically covers the development of
activatable fluorescent architectures but does not include
macrophage imaging probes based on genetically-encoded
reporters, non-activatable fluorophores1 or nanomaterials,
which have been reviewed elsewhere.2
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1.2. Macrophages: a case-study for imaging cellular activity
Macrophages display a broad range of cellular functions, and
their activity has been associated with many diverse biological
processes. They are phagocytic cells that recycle and clear cells
during inflammatory processes, and remove pathogens upon
infection. Macrophages also play a critical role in tissue repair
and remodelling, as well as in the orchestration of the host
response to infectious diseases through secretion of cytokines,
enzymes and reactive oxygen species (ROS), the downside of
which is a major role in fibrotic scarring of damaged tissues.3
There is evidence that macrophages are essential in the tumour
microenvironment, actively participating in tumour growth,
metastasis and progression to malignancy, and the number and
phenotype of macrophages also influence the fate of atherosclerotic
plaques in cardiovascular diseases and neurodegenerative
disorders. All these properties make macrophage activity a
relevant target for diagnostic and therapeutic exploitation,
which has prompted the development of suitable imaging
probes in the last few years.
We have structured our review according to different mole-
cular targets in macrophages that are employed to trigger the
emission of smart fluorophores. Notably, these targets not
only define the biological context in which the activity of
the macrophages is imaged but also they pre-determine the
main chemical features of the smart fluorescent probes to be
employed, which can range from reactive small molecule
fluorophores to intramolecular-quenched peptides or activity-
based probes. We have grouped smart fluorescent probes for
macrophages into two large families: (1) probes targeting
intracellular activity (e.g. ROS, pH gradients, phagocytosis)
(Section 2), and (2) probes monitoring enzymatic activity
(e.g. matrix metalloproteases (MMPs), cathepsins) (Section 3).
Finally, we have also incorporated a section on the preparation
of fluorophores using diversity-oriented fluorescence libraries
as an alternative strategy to discover unique structures for
macrophage imaging (Section 4).
As illustrated in Fig. 1, the broad array of macrophage
functions in healthy and pathological states has stimulated the
preparation of chemical structures with various fluorescence
amplification mechanisms. Smart probes based on small molecule
fluorophores are ideal to target intracellular macrophage activity,
which correlates with gradients of pH in phagocytic macro-
phages or high levels of ROS in infected areas. Their excellent
cell permeability and rapid kinetics are essential to ensure the
correct localisation of these probes and their ability to react with
short-lived molecular species (e.g. ROS, reactive nitrogen species
(RNS)). Larger structures are typically required to image enzy-
matic activity in macrophages, which is often associated to the
remodelling of the extracellular matrix in inflammatory and
cancerous disorders. Smart substrate-based probes exploit the
proteolytic activity of these enzymes (e.g. MMPs, cathepsins) to elicit
a fluorescent response upon recognition by the active enzyme. Their
amplification mechanisms are either linked to the dequenching of a
fluorophore or to the efficient Förster resonance energy transfer
(FRET) between fluorescent donor and acceptor moieties. On the
other hand, activity-based probes react with nucleophiles in
the catalytic sites of enzymes (e.g. cysteines in the active site of
cathepsins) to form irreversible bonds. Every family of enzymatic
probes has advantages and shortcomings (e.g. fluorescence ampli-
fication, adaptability to proteomic analysis, kinetics); hence they
must be fine-tuned to meet the requirements of the biological
imaging studies. Finally, diversity-oriented fluorescence libraries
are a good source of smart probes to image macrophages in
biological or medical contexts where little is known about the
molecular markers that are associated with macrophage activity.4
Their simplicity and direct applicability make them useful
tools for translational imaging (e.g. intraoperative imaging,
fluorescence-guided surgery).
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2. Targeting intracellular macrophage
activity
2.1. Reactive oxygen and nitrogen species
ROS and RNS are directly associated with many functions of
macrophages. Macrophages produce and release ROS in response
to phagocytosis of microbes or after stimulation by different
agents in connection with bacterial killing, inflammation or tissue
injury. Macrophages also produce ROS as a second messenger
to regulate signalling pathways involved in cell proliferation,
apoptosis and gene expression.
Hydrogen peroxide (H2O2) is one of the most important
endogenous ROS in macrophages. In phagocytic cells, the
oxidase NOX2 is activated to produce superoxide (O2
), which
undergoes dismutation to form H2O2 and later hypochlorous
acid (HOCl). Owing to its short lifetime, the levels of H2O2 in
macrophages are estimated to be in the lower nanomolar range,
thus requiring highly sensitive probes for real-time imaging. Most
of the smart probes for the visualisation of H2O2 in macrophages
rely on small molecule fluorophores containing H2O2-reactive
moieties. Boronates, disulfonates and benzoylcarbonyl groups
have been employed for this purpose. The incorporation of
these groups at specific positions of fluorescent scaffolds
modulates their internal charge or electron transfer properties so
that fluorescence is only elicited upon chemoselective cleavage
with H2O2. The group of Chang has become one of the most
prolific labs in the development of smart fluorophores for imaging
H2O2 by exploiting the chemospecific boronate-to-phenol switch.
5
Notably, the incorporation of reactive boronate groups has
proven compatible with various fluorescent scaffolds with diverse
spectral properties. An interesting example of this adaptability has
been the preparation of a palette of boronate-based rhodol and
fluorescein smart probes with high quantum yields and varying
emission wavelengths (1, Fig. 2).6 Such versatility allowed to
perform multiplexing experiments to simultaneously monitor
the fluxes of H2O2 and HOCl in the phagosomes of stimulated
macrophages. Disulfonate groups have been also used as reactive
moieties for imaging the intracellular production of H2O2 in
macrophages. Disulfonate probes based on naphthofluorescein,
a scaffold with red-shifted spectral properties when compared to
fluorescein, were reported as smart probes for H2O2 in mice
peritoneal macrophages (2, Fig. 2). These compounds showed
good selectivity for H2O2 over other ROS and very low detection
limits, in the pM range.7 More recently, Nagano et al. prepared
Fig. 1 A myriad of smart fluorescent architectures to image macrophage activity. The broad diversification of macrophage activity has enabled the
development of very diverse smart probes to visualise their functions in vitro and in vivo. Smart fluorescent probes can be activated by different molecular
targets (e.g. reactive oxygen/nitrogen species (ROS/RNS), matrix metalloproteases (MMPs), cathepsins, preferential cell uptake, or phagocytic activity)
that are related to different biological events and pathological states (e.g. infection, inflammation, tissue injury, atherosclerosis, cancer, tissue
remodelling). Examples of smart fluorescent chemical probes include reactive or pH-sensitive small molecule fluorophores, quenched peptides,
activity-based enzyme probes or diversity-oriented fluorescence libraries. Abbreviations: COPD: chronic obstructive pulmonary disease, FRET: Förster
resonance energy transfer, D: donor, A: acceptor, F: fluorophore, Q: quencher.
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5-(4-nitrobenzoyl)carbonylfluorescein (NBzF) as a highly sensi-
tive probe for H2O2 regulated by donor-excited photoinduced
electron transfer (d-PeT) with a remarkable 150-fold fluores-
cence increase after activation (3, Fig. 2).8 The corresponding
diacetylated version, showing improved cell permeability, was
used to visualise the production of H2O2 in activated murine
macrophages. Subsequent studies have led to the adaptation of
NBzF for SNAP-tag labelling, opening the possibility to visualise
the production of H2O2 in specific subcellular compartments.
9
Fluorescent scaffolds with enhanced spectral properties can
provide additional benefits. Ratiometric probes, which are self-
referenced and thus concentration-independent, have been
derivatised with boronate groups to produce 1,8-naphthalimide-
based imaging probes with blue-to-green shifts upon reaction
with H2O2 and compatibility with two-photon imaging.
10 The
engineering of cyanine–xanthene probes with an optically tunable
hydroxyl group has led to smart fluorescent architectures with
suitable properties for in vivo imaging, due to their emission
in the near-infrared region of the spectrum.11
The potential cross-reactivity of some of the reactive
moieties and the short lifetime for most ROS/RNS hampers
the selective targeting of these species. Nagano et al. observed
cross-reactivity of their H2O2-sensitive benzoylcarbonyl probe
NBzF with peroxynitrite (ONOO),8 a RNS formed by the reac-
tion between nitric oxide (NO) and O2
 in inflammatory cells.
Likewise, boronates have been employed to produce smart
probes for imaging ONOO. Kim et al. recently reported the
synthesis of a boronate coumarin precursor with rapid intra-
molecular cyclisation and subsequent fluorescence activation
upon reaction with ONOO (4, Fig. 2).12 In vitro characterisa-
tion assays indicated the preferential reactivity of the probe for
ONOOover other RNS and ROS (including H2O2), although the
fact that cell imaging assays were performed in macrophages
activated under generic stimulation conditions (e.g. LPS, IFNg)
does not rule out the possibility that other ROS/RNS could be
detected using these boronate derivatives. The group of Yang
developed rhodol-based reactive structures with intramolecular-
quenching N-phenyl groups that triggered fluorescence emission
upon reaction with ONOO and subsequent N-dearylation.
Initial attempts employed a trifluoromethyl ketone as the
warhead reactive group. These probes were later optimised by
screening of different N-phenylrhodol derivatives for selectivity
towards ONOO over other ROS (HOCl). The N-phenylrhodol
derivative HKGreen-4 (5, Fig. 2) showed a remarkable amplifica-
tion in ONOO after two-electron oxidation and formation of an
iminium ion that was further hydrolysed to release the highly
fluorescent N-dearylated rhodol.13 HKGreen-4 was employed to
image increased endogenous levels of ONOO in Escherichia coli-
challenged macrophages, and its selectivity was corroborated
by blockage with nitric oxide synthase (iNOS) and NADPH
oxidase (NOX) inhibitors. These probes will allow to image
macrophage activity at infection sites as well as studying the
bactericidal effects of ONOO production.
One major limitation of smart fluorescent probes that rely
on the conjugation of quenching reactive moieties to small
molecule fluorophores is their irreversibility, which impedes
continuous monitoring of ROS/RNS in real time. This limita-
tion was recently overcome with the preparation of a reversible
near-infrared tricarbocyanine smart probe (Cy-PSe) containing
an organoselenium functional group for real-time monitoring
of ONOO in live macrophages (6, Fig. 2).14 The fluorescence
emission of Cy-PSe remained low in the basal state due to PeT
quenching but was activated through selective Se oxidation with
ONOO (23-fold fluorescence increase). Notably, the oxidised
fluorescent structure reverted back to the ‘off’-state after
Fig. 2 Smart fluorescent probes for imaging intracellular activity in
macrophages. Representative structures of reactive fluorophores for the
detection of ROS/RNS as well as other metabolites associated to macro-
phage activity. The different probes are classified according to their
targets: H2O2, ONOO
, NO, HOCl, O2
, OH, H2S, phagocytic pH and
histamine. The different chemical reactive groups in the smart probes
are highlighted in bold and in the colour of the resulting fluorescence
emission after activation.
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glutathione reduction within 5 min. This unique family of
probes might become a useful tool to monitor longitudinally
the production and elimination of ROS in macrophages in a
non-invasive manner.
Nitric oxide (NO) is an indispensable biological mediator
produced by nitric oxide synthase (NOS2), whose expression in
macrophages is regulated by cytokines and microbial products.
Macrophages present high levels of NOS2 upon infection or
inflammatory stimuli so that the endogenous release of NO
produces a cytotoxic and protective response against infectious
agents (e.g. viruses, bacteria, fungi). The development of smart
fluorophores for imaging NO in macrophages still very much
relates to the seminal work of Nagano and colleagues with
the conjugation of o-diaminebenzene groups to fluorescent
scaffolds.15 Nagano’s approach relies on the formation of N2O3
from NO in aerobic conditions and its subsequent reaction with
o-diamine groups – which behave as intramolecular PeT quench-
ers – to produce highly fluorescent electron-deficient triazoles.
This strategy has proven compatible with all sorts of fluorescent
structures (e.g. BODIPY, cyanine, rhodamine, fluorescein),
including hybrid and ratiometric dyes. An interesting example
was described by the group of Lin with one of the first reports of
ratiometric imaging of endogenous NO in macrophages using
a highly sensitive coumarin–rhodamine hybrid (LOD: 30 nM)
(7, Fig. 2).16 The design of these probes, however, suffers from
two limitations: (1) o-diaminoaromatic groups show cross-
reactivity with dehydroascorbic acid (DHA), and (2) their activa-
tion relies on the formation of N2O3, implying that NO cannot
be detected under hypoxic or anoxic conditions. Regarding
the former, o-hydroxyamino groups have been employed to
minimise the reactivity for DHA at the expense of increasing
the LOD for NO to the low micromolar range.17 As for the
latter, Lippard et al. described an alternative approach
for sensing NO in macrophages based on the preparation of
transition metal complexes with small fluorophores. Metal-
fluorophore complexes exploit the close proximity of the fluoro-
phore to the metal to quench the fluorescence emission until it
reacts with NO. One elegant example of this strategy was
described in the synthesis of seminaphthofluorescein Cu(II)
complexes (8, Fig. 2) with red-shifted emission properties
and their application to imaging endogenous NO in IFN-g and
LPS-stimulated macrophages.18
Hypochlorous acid (HOCl) is an oxidant molecule formed by
the reaction between a chloride ion and hydrogen peroxide,
which is catalysed by the enzyme myeloperoxidase (MPO). Like
other ROS, HOCl is generated as part of the host immune
protection to infection, but abnormal levels of MPO are also
implicated in the pathogenesis of atherosclerosis and other
inflammatory states. Libby et al. reported a sulfonaphthoamino-
phenyl fluorescein (SNAPF) for the selective detection of HOCl in
MPO+ macrophages (9, Fig. 2).19 Monocytes and neutrophils are
immune cells with high expression levels of MPO; however, only
MPO+ macrophages can be found in atherosclerotic plaques,
thus being a potential biomarker to predict risk for coronary
events and myocardial infarction. Upon activation with HOCl,
SNAPF displayed a remarkable fluorescence increase in the far
red region of the spectrum. The red-shifted emitting properties
of SNAPF are an important asset given the potential interference
from autofluorescent elastin-rich arterial tissues. SNAPF was
validated in vitro as well as in MPO+ stimulated macrophages,
and provided one of the first reports of direct imaging of HOCl
in tissue sections of human atherosclerotic plaques. Other
fluorescent probes have been reported to image HOCl in macro-
phages using a relatively broad range of activatable groups and
small fluorophores. These include non-fluorescent thiosemi-
carbazides as precursors of highly fluorescent oxadiazoles,20 or
BODIPY-phenols with high fluorescence amplification upon
oxidation to the corresponding quinones with reduced intra-
molecular PeT quenching. This latter family of probes has been
subjected to optimisation studies to enhance the chemical stability
by derivatization with halogen groups, leading to successful probes
for imaging endogenous HOCl in THP-1 human macrophages
(10, Fig. 2).21 Recently, the group of Chang has developed a new
class of probes for imaging HOCl with subcellular resolution using
two-photon microscopy.22 Two-photon microscopy provides high
resolution with deep tissue penetration and minimal phototoxicity
as it employs long excitation wavelengths. The authors derivatized
acedan, a two-photon-compatible fluorophore, with an oxathiolane
HOCl-reactive group as well as mitochondria and lysosome-
targeting moieties (i.e. triphenylphosphine and morpholine,
respectively) (11a and 11b, Fig. 2). The resulting probes were used
for in vitro imaging of macrophage activity and in vivo imaging in
relevant mouse models of inflammation. These smart probes will
be important to study the trafficking and subcellular localisation
of ROS and ROS-related enzymes (e.g. MPO) in vivo.
Superoxide (O2
) is one of the few ROS that can be detected with
chemical architectures that undergo either oxidative or reductive
activation mechanisms. Reduced fluorophores (e.g. hydroethidine,
dihydrofluorescein, dihydrorhodamine) are widely used as commer-
cially available reagents for general measurements of O2
. However,
one of the main limitations of these reagents is their potential
cross-reactivity with other ROS. Following the pioneering work of
Itoh et al. in the preparation of probes for O2
 relying on a non-
redox mechanism,23 the group of Tang reported the synthesis of
phosphinate-based architectures to image endogenous levels
of O2
 in macrophages.24 The design of these phosphinate-
protected fluorophores relies on the nucleophilicity of O2
 to
‘uncage’ the fluorescent core and release a bright fluorescent
signal (12, Fig. 2). These probes were prepared in one single
step by conjugation of diphenylphosphinic chloride to either
fluorescein (for green emission) or naphthofluorescein (for red
emission), and underwent chemical deprotection only after
incubation with O2
 but not other with other ROS. Their high
selectivity allowed to visualise the endogenous production of
O2
 in peritoneal mouse macrophages after activation with
phorbol myristate acetate (PMA), and their specificity was
demonstrated by inhibition of the fluorescence signal upon
treatment with Tiron, a non-enzymatic O2
 scavenger.
Less usual chemical architectures have been employed for the
detection of very reactive species, such as hydroxyl radicals (OH)
with lifetimes in aqueous media in the range of nanoseconds.
The detection of these intracellular species in macrophages is
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extremely challenging, not only because of their short lifetimes
but also due to the potential interference from ONOO, which
has similar oxidation capacity. Tang et al. designed a smart
fluorophore for OH imaging based on a tetraphenyl-BODIPY
derivative attached to the 4-hydroxy-TEMPO (4-hydroxy-2,2,6,6-
tetramethyl-1-piperidinoxyl) moiety (13, Fig. 2).25 The authors
exploited the high reactivity of the nitroxide group of TEMPO
towards methyl radicals to form fluorescent methylated BODIPY
derivatives in environments with high levels of OH and DMSO
(acting as the source of methyl radicals). This approach allowed
imaging of OH in stimulated macrophages with very low
detection limits (LOD: 18 pM). However, the need for high
concentrations of DMSO – in the milimolar range – might
compromise the applicability of this strategy to visualise the
release of OH in vivo.
2.2. Other intracellular biomarkers and phagocytic activity
In addition to ROS and RNS, macrophages produce a wide
range of metabolites that can be used as indicators of their
intracellular activity. Hydrogen sulfide (H2S) is a signalling
molecule that plays an important role in a vast number of
physiological and pathological states. Macrophages, among
other cells, produce H2S endogenously from cysteine with the
involvement of cystathione b-synthase and cystathione g-lyase
enzymes. Smart fluorescent probes for H2S have been generated
following similar strategies to the ones described above for
ROS, mainly conjugating reactive moieties to small fluoro-
phores at sensitive positions for electron or charge transfer.
An internal charge transfer (ICT) BODIPY derivative was pre-
pared by conjugation of the 1,3-dimethyl-BODIPY core to an
aromatic aldehyde with an ortho-a,b-unsaturated acrylate
methyl ester group (14, Fig. 2).26 While the meso position of
the BODIPY scaffold is preferred to introduce PeT quenching
moieties, this H2S-reactive moiety was conjugated to the posi-
tion 3 of the BODIPY scaffold. This modification not only led to
effective ICT but also red-shifted the fluorescence emission
properties of the BODIPY scaffold. The resulting probe (ZS1)
reacted with H2S to produce a five-membered hemithioacetal
ring with remarkable fluorescence emission. ZS1 showed
good selectivity for H2S over other biothiols and was used to
monitor the changes in H2S levels in murine macrophages.
Macrophages were stimulated with PMA to increase the pro-
duction of ROS, which subsequently led to a reduction of the
endogenous levels of H2S. Therefore, the decrease in the
fluorescence emission of ZS1 (due to the decrease in H2S levels)
was used as an indirect readout of the ROS activity in macro-
phages. Although the quantification of decreases in fluores-
cence emission is often more complex than for enhancement
signals, these fluorescent probes might be used to study redox
cycles between ROS-induced oxidative stress and H2S-mediated
repair, either alone or in combination with some the above
mentioned ROS-sensitive fluorophores. Other H2S-reactive moi-
eties include dinitrophenyl ethers, which can be readily incor-
porated into coumarin-based scaffolds to produce ratiometric
probes.27 Yuan et al. conjugated a H2S-sensitive coumarin
scaffold to rhodamine, which favoured mitochondrial localisation
and was used as an internal reference since its emission
remained unchanged with H2S activation. This example high-
lights the benefits of ratiometric structures to minimise fluc-
tuations in the readout due to variations in the concentration of
the probes, cell confluency or the efficiency of the activation
mechanism.
Phagocytosis is one of the main functions of macrophages.
Macrophages are professional phagocytes which help to clear
necrotic cells, pathogens as well as other tissue components
after injury. The clearance of apoptotic cells (e.g. neutrophils)
has been also identified as a key step in the resolution of
inflammatory processes. Imaging macrophage phagocytosis
has been traditionally achieved with nanomaterials – generally
compatible with molecular resonance imaging (MRI), such as
iron oxide or gadolinium nanoparticles – that preferentially
accumulate in macrophages. These nanomaterials are excellent
tools for in vivo studies using MRI. Recent progress in optical-
based modalities has enabled imaging the phagocytic cascade
in macrophages using multimodal MRI-optical composites or
novel smart fluorophores.
Vendrell and Lavilla et al. developed a synthetic strategy to
prepare smart fluorophores for imaging phagocytic activity in
macrophages.28 The authors optimised the adaptation of multi-
component reactions (i.e. convergent reactions where three or
more starting materials react to form a new product under
a unified mechanism) to the BODIPY scaffold to synthesise
derivatives via Ugi, Passerini and Bienaymé–Blackburn–Groebcke
reactions. Using this approach, a highly sensitive smart fluoro-
phore (PhagoGreen) was generated to image phagosomal acidifi-
cation in macrophages (15, Fig. 2). PhagoGreen has a pKa of 5.7,
which is in accordance with the pH values observed in late
phagosomes in macrophages, and showed a preferred localisation
into intracellular vesicular structures, making it an ideal probe to
monitor the pH changes associated to the maturation of the
phagosomes. Notably, the authors proved the selective activation
of PhagoGreen in zymosan-stimulated macrophages by treatment
with bafilomycin A, an inhibitor of the vacuolar-type H+-ATPase
that is essential for the acidification of the phagosomes. The high
selectivity and sensitivity of PhagoGreen enabled its application
for in vivo imaging of phagocytic macrophages in zebrafish in real
time (Movies S1 and S2 in ESI†). The colocalisation of PhagoGreen
with macrophage markers and the discrimination between early
(non-acidic and non-fluorescent) phagosomes and late (acidic and
highly fluorescent) phagosomes validate PhagoGreen as a versatile
smart fluorescent probe for imaging phagocytic macrophage
activity in vivo, and represents an optical alternative to MRI-
active nanomaterials. Multicomponent reactions have been also
employed for the preparation of other smart fluorescent probes
for imaging macrophages. Of note is the development of Hista-
mine Blue, a mesoionic acid fluoride with enhanced fluorescence
emission upon reaction with histamine (16, Fig. 2).29 While
limited to short excitation and emission wavelengths, Histamine
Blue enabled direct imaging of intracellular histamine in macro-
phages that were treated with thapsigargin, a Ca2+ ATPase
inhibitor that blocks the last stage of the autophagic process
involving the fusion of autophagosomes and lysosomes.
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3. Monitoring the enzymatic activity of
macrophages
3.1. Quenched probes for imaging MMPs
MMPs constitute a family of zinc-dependent proteases, which
can degrade most tissue components. In humans there are
23 different MMPs, whose activities are regulated at different
levels, being directly associated with various physiological
processes (e.g. wound repair, tissue remodelling) and pathologies
(e.g. cancer, arthritis, atherosclerosis). In this section, we will
specifically cover smart fluorescent probes for MMPs that can
be employed to image the activity of macrophages (excluding
other cell types, such as cancer cells or fibroblasts) in different
biological contexts.
Some of the first attempts for optically imaging MMPs were
based on poly-L-lysine structures containing self-quenched
fluorescent groups that were released upon MMP cleavage.
This strategy was employed to generate smart near-infrared
probes for in vivo visualisation of MMP-2 and MMP-9 activity in
macrophages using mouse models of atherosclerosis.30 Near-
infrared fluorophores offer important advantages for in vivo
imaging due to minimised tissue autofluorescence and deeper
penetration into tissue, which facilitates their use for whole-body
fluorescence molecular tomography (FMT) and reflectance imaging
studies. The authors modified the GGPRQITAG sequence
(a peptide substrate for MMP-2 and MMP-9) with the near-
infrared cyanine dye Cy5.5 (excitation: 675 nm, emission:
694 nm). The close proximity of the different Cy5.5 fluorophores
within the polymeric structure resulted in a non-fluorescent
basal state, which changed into a highly fluorescent response
upon MMP cleavage and subsequent release of the fluorophores
to the media. Using these probes, the authors observed high
levels of MMP-2 and MMP-9 activity in the atherosclerotic aortas
from apolipoprotein E-deficient (apoE/) mouse models, which
have impaired clearing of plasma lipoproteins and develop
atherosclerosis in a short time. Notably, the authors performed
co-localisation experiments with macrophage-specific markers
(Mac3) and confirmed that areas showing high MMP activity
were rich in macrophages, whereas fibrous plaques with low
MMP activity contained few macrophages. These smart fluores-
cent probes show potential as novel diagnostic tools to inter-
rogate atheroma inflammation and identify patients with high
risk of cardiovascular diseases.
One limitation of self-quenched polymers is their inherently
large molecular weight. Whereas large macromolecules can be
advantageous for tissue retention and enhanced contrast, their
relatively long half-lives in circulation may be detrimental for
translational imaging. As a result, there has been an interest in
developing smaller probes that can be selectively activated by
MMPs. Many of these probes are based on internally quenched
peptides containing one specific MMP substrate peptide flanked by
two chromophores, either a donor–acceptor fluorescent pair or a
fluorophore–quencher pair. The main requirement for selecting an
effective donor–acceptor fluorescent pair is the overlap of their
spectral properties (i.e. emission donor matching excitation acceptor)
for efficient FRET between the chromophores. These probes
typically display higher quenching efficiencies than self-quenched
polymers and also offer the possibility of reading ratiometric
measurements when a donor–acceptor fluorescent pair is used.
FRET quenched peptides represent the vast majority of fluores-
cent reagents for MMPs and, despite not being highly selective,
they have been widely used as tracers for imaging MMP activity in
macrophages. One exceptional example of the utility of these
reagents was recently reported by Werb et al., who performed
intravital imaging of tumour-associated macrophages in breast
cancer mouse models.31 The authors employed the commercial
probe MMPSense 680 to monitor the proteolytic activity of several
MMPs (mainly 2, 9, 12 and 13) in the tumour microenvironment
in real time. Notably, most of the MMP activity was observed in
myeloid cells, which included macrophages and dendritic cells
but not neutrophils. The treatment with anti-CSF1R antibody
(i.e. an experimental anticancer therapy) delayed tumour
growth and depleted dramatically MMPSense 680-labelled cells,
indicating their active role in promoting angiogenesis, invasion,
and metastasis. This study highlights the potential of combining
smart fluorescent probes with high-resolution intravital imaging
technologies to unveil key functions of macrophages in the
tumour microenvironment and to advance in the validation of
novel anticancer therapies.
Different chemical strategies have been explored to enhance the
selectivity of smart fluorescent probes for MMPs. One revolutionary
chemical design was reported by Tsien et al. with the preparation of
activatable cell-penetrating peptides (ACPPs).32 These architectures
consisted of polyarginine-based cell-penetrating peptides, whose
cellular uptake was blocked by an inhibitory domain made up
of negatively charged residues. ACPPs employ MMP-cleavable
linkages between the two domains so the internalisation and
subsequent detection of the cell-penetrating peptide is depen-
dent on MMP activity. This concept has been extrapolated to
engineering large macromolecules with high selectivity for acti-
vated macrophages, with the derivatisation of binding domains
for scavenger receptors (i.e. cell surface-markers of macrophages
in atherosclerotic lesions) using MMP-9 activatable linkers.33
Enhanced cellular targeting can be also achieved by incor-
poration of lipid motifs to quenched MMP-activatable peptides.
The group of Schultz developed a ratiometric FRET probe for
imaging MMP-12 activity in macrophages involved in pulmon-
ary inflammation (Fig. 3).34 The authors derivatised the peptide
sequence PLGLEEA (with good selectivity for human and
mouse MMP-12) using different combinations of FRET fluoro-
phore pairs (e.g. coumarin343/TAMRA (LaRee1), coumarin343/
methoxycoumarin (LaRee5)) to obtain probes with detection
limits for MMP-12 in the low nanomolar range. A remarkable
feature of Schultz’s design was the incorporation of a palmitic
acid at the N-terminal group of the FRET peptides. The lipid
moiety targeted the probe LaRee1 to the plasma membrane
(where MMP-12 is mainly localised in activated macrophages) and
facilitated the internalisation and intracellular accumulation of
one of the fragments after the proteolytic cleavage, producing a
memory effect on macrophages with MMP-12 pericellular activity.
Imaging studies of LaRee1 in LPS-stimulated macrophages
confirmed the MMP-12 activity not only by loss of FRET but
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also by accumulation of one of the fragments in internal
membranes (Fig. 3 and Movies S3, S4 (ESI†)). LaRee1 was
employed to monitor the proteolytic activity in bronchoalveolar
lavage samples from mouse models of pulmonary inflamma-
tion and compared to untreated and Mmp12/ mice. These
assays identified alveolar macrophages as the main cell type
showing MMP-12 activity at the plasma membrane in inflamed
lung tissue, and confirmed the importance of their stimulation
in several inflammatory lung diseases. The development of this
family of smart probes represents an important step forward
towards the validation of MMP activity as a biomarker for
chronic obstructive pulmonary disease (COPD).
3.2. Activity-based probes targeting cathepsins
Cysteine cathepsins constitute a family of 11 proteases with an
essential role in the breakdown of proteins. Being macrophages
key players in tissue modelling, many of their functions are
directly related to the expression and/or secretion of cathepsins,
which have been associated with several pathological diseases,
including cancer, arthritis or COPD. Most cathepsins are
Fig. 3 FRET probes for imaging MMP-12 activity on macrophages. (a) Chemical structure of the FRET probe LaRee1 incorporating coumarin343 as the
donor and TAMRA as the acceptor. (b) Time-course fluorescence microscopy images of macrophages after treatment with LaRee1 and recombinant
MMP-12: t = 0, coumarin343 fluorescence emission was quenched and TAMRA showed sensitized emission, t = 4 and 10 min: strong ratiometric change
was observed and the green fluorescence shifted from the plasma membrane to the cell interior (scale bar: 10 mm). (c) Plots of coumarin343 and TAMRA
fluorescence emission traces at the plasma membrane and in the cytosol over time. (d) After LaRee1 was added to LPS-stimulated macrophages, the
emission ratio was accompanied by an increase of green fluorescence inside cells (top panel) and a loss of FRET signal emission (centre panel). Direct
TAMRA excitation showed the predominant plasma membrane location of the remaining intact reporter and demonstrated extracellular cleavage
(bottom panel) (scale bar: 20 mm). (e) MMP activity was found on LPS-stimulated macrophages (top panel) but not in unstimulated ones (centre panel) or
those stimulated but also treated with the MMP inhibitor GM6001 (bottom panel). (f) LaRee1 images MMP12 activity from wild-type (WT) and Mmp12/
mice that were challenged with particulate fraction or vehicle by intratracheal instillation. (g) Quantification of MMP-12 activity showed a significant
increase in WT particulate-challenged mice compared to control or Mmp12/ mice. Reproduced with permission from the Nature Publishing Group.34
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activated at low pH; hence their activity is preferentially localised
in the lysosomes, which are membrane-bound cellular organelles
enclosing numerous enzymes for protein degradation.
Analogous to the above mentioned MMP probes, co-polymers
have been also adapted as smart fluorescent probes for imaging
cathepsin activity. These structures are the basis of the commer-
cially available ProSense probes, and represent powerful tools to
visualise cathepsin activity in macrophages. Weissleder et al.
reported the preparation of Cy5.5-labelled co-polymers including
the sequence GHPGGPQKC as smart fluorescent probes with
high selectivity for cathepsin K (CatK).35 These polymers were
used to monitor the activity of CatK in vivo in the experimental
murine atherosclerosis model apoE/ (described above in
Section 3.1). The authors observed high fluorescence signals in
atherosclerotic plaques due to the increased CatK activity,
which correlated with areas of elastin fibre disruption and high
abundance of macrophages. Similar results were obtained in
fresh carotid human atheroma specimens, asserting the
potential of these probes for translational imaging.
Smart probes that emit fluorescence only after recognition by
active cathepsins are advantageous because they provide a direct
readout of the maturation of the proenzymes, helping to under-
stand their function in healthy and disease states. To this end,
activity-based probes (ABPs) have enabled direct imaging and
profiling of cathepsin activity in vivo. ABPs are designed to be highly
specific for the catalytically active form of the enzyme, and they
typically consist of three components: (1) a chemical group or
‘warhead’ that reacts irreversibly with the nucleophile at the active
site of the cathepsin, (2) a binding region for enzyme specificity,
which can be of peptidic or non-peptidic nature, and (3) a reporter
system (e.g. typically a fluorophore alone or a fluorophore–quencher
pair) for direct visualisation of the tagged enzymes (Fig. 4).
Over the last 10 years, the group of Bogyo has remarkably
accelerated the development of ABPs for imaging cathepsin
activity in macrophages. Initial designs of ABPs consisted of
peptide acyloxymethylketones (AOMKs) as the electrophilic
group to react with cysteine residues at the catalytic site, and
Cy5 as the fluorescent reporter (the Cy5:QSY21 pair was used as
a fluorophore:quencher pair for the preparation of internally
quenched ABPs).36 This group of smart probes offer the advan-
tage of monitoring the labelling of specific cathepsins by SDS-
PAGE analysis, which allows to assign unequivocally the activity
of different cathepsins to the fluorescence signals observed
during imaging experiments. Cathepsin-targeted ABPs have been
used in vivo to identify the cathepsins that are activated in
macrophages during colitis (i.e. inflammation of the colon)
and to dissect some of the signalling pathways involved.37
Fluorescent ABPs with high affinity for CatB, CatL and CatS were
employed in experimental models of colitis using in vivo FMT
imaging and subsequent proteomic characterisation. These
studies revealed the activation of cathepsins (primarily CatS) in
macrophages in the inflamed colon, and identified CatS as a
mediator molecule for colonic pain. ABPs have accelerated the
validation of cathepsin inhibitors as potential therapies for
colitis and will become important tools for the early diagnosis
of colonic disease via fluorescence endoscopy.
One of the main limitations of ABPs over substrate-based
enzyme-activatable probes is the lack of amplification. Whereas
one molecule of the target enzyme can cleave (and therefore
activate) many substrate-based probes, the irreversible covalent
binding between the reactive ABP and cysteine at the catalytic
site results in the inactivation of the enzyme, thus limiting the
amplification of the fluorescent signal. In order to compensate
this shortcoming, the binding affinity and electrophilicity of the
‘warhead’ of ABPs need to be finely tuned. A second generation of
non-peptidic ABPs with high affinity for CatS was generated using
CatS-selective 1,4-disubstituted-1,2,3-triazole inhibitors developed
by the group of Ellman as the main scaffold (Fig. 4).38 The authors
replaced the norleucine group with a lysine residue that allowed
the incorporation of a Cy5 fluorophore, and used the previously
validated 2,6-dimethyl benzoic AOMK as the electrophilic warhead
with a pendant QSY21 quencher for near-infrared fluorescence
activation. The resulting non-peptidic ABPs maintained the
potency of previous peptidic ABPs while showed enhanced
selectivity for CatS in human monocyte-derived macrophages
and bone-marrow derived mouse macrophages. High activity
CatS levels have been reported for tumour-recruited macro-
phages, which contribute to tumour progression and are asso-
ciated with poor prognosis in many cancers. In vivo imaging
studies in breast cancer mouse models proved the utility of
these quenched ABPs to image and report cathepsin activity in
tumour-associated macrophages (validated as CD11b+ and
macrophage mannose receptor (MMR)+ cells). These smart
fluorescent probes are excellent tools to image and characterise
subpopulations of macrophages in the tumour microenviron-
ment, and have opened different research avenues to enhance
prognosis in cancer patients.
Further modifications on ABPs have been aimed at optimising
their properties for different applications. Zhang et al. developed
trifunctional ABPs incorporating an octa-arginine cell-penetrating
peptide to perform cathepsin proteomic profiling studies inside
living macrophages.39 These ABPs contained one fluorophore
(i.e. fluorescein) and one biotin motif, which facilitated the
enrichment, purification and visualisation of the active enzymes
in live cells to identify active cathepsins in their native environ-
ment with very high sensitivity. As a result, the authors were able to
detect for the first time low abundant cathepsins (i.e. cathepsins
F and O) in live macrophages.
Verdoes and Bogyo et al. have also systematically optimised
the different components of their quenched ABPs to enhance
their biodistribution and in vivo applicability.40 First, the incor-
poration of a sulfonated quenching moiety and exploration of
different linkers between the electrophile and quencher groups
resulted in an improvement of the water solubility of their ABPs.
Furthermore, modifications in the electrophilic ‘warhead’
demonstrated the tunability of ABPs to target different enzyme
populations. This is an advantage of ABPs over substrate-based
architectures, as the binding/reactive moieties can be fine-tuned
to be highly specific or non-specific for different subfamilies
of proteases. In order to develop a pan-reactive cathepsin
probe, the authors replaced the 2,6-dimethylbenzoic acid-derived
AOMK with a 2,3,5,6-tetrafluoro-substituted phenoxymethyl ketone,
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which is smaller and displays greater reactivity against cysteine
residues. The resulting ABPs exhibited enhanced serum stability
and kinetics, near-infrared fluorescence emission properties
and broad cathepsin reactivity (i.e. cathepsins B, L, S and X) in
both mouse and human monocyte-derived macrophages. Non-
invasive in vivo imaging of macrophage activity in breast cancer
mouse models confirmed the primary function of these cathepsins
in CD68+ tumour-associated macrophages. Pan-reactive ABPs
have improved current diagnostic tools for conditions where
multiple macrophage cathepsins are involved. These smart
probes have also opened the possibility to perform multiplexed
imaging experiments with complementary ABPs. A recent
report demonstrates the potential of dual-color macrophage
imaging by combining ABPs that are highly selective for CatS
with pan-reactive probes (Fig. 4).41 This unique toolbox enabled
the visualisation of CatS in relation to other cathepsins, and
indicated some key differences in the subcellular localisation of
CatS between macrophages and dendritic cells.
The rapid activation of quenched ABPs, which emit fluorescence
only upon cleavage by cathepsins, renders high signal-to-noise
ratios at very early time points compared to non-activatable
versions or substrate-based probes. This is an essential feature
when rapid readouts are required, such as pre-screening exam-
inations or clinical interventions. Quenched ABPs have been
Fig. 4 Activity-based smart fluorescent probes for imaging cathepsin activity. (a) Schematic representation of cathepsin activity-based probes, where
the active cysteine at the catalytic site reacts with the electrophilic warhead to form an irreversible bond and dequench the fluorophore. (b) Chemical
structure of BMV083, a CatS-directed smart probe. (c) Labelling profile of BMV083 in living human primary macrophages. Cells were exposed to the
indicated concentrations of BMV083 for 3 h, before being harvested, washed, and lysed. Total protein was resolved on 15% SDS-PAGE, and fluorescently
labeled proteins were visualised by in-gel fluorescence scanning. (a–c) Reproduced with permission from Cell Press.38 (d) Confocal microscopy images
of mouse bone-marrow derived dendritic cells exposed to a red CatS-directed smart probe (BMV157) and a green pan-reactive cathepsin probe (EM053);
biochemical characterisation of the dual probe system by SDS-PAGE in bone-marrow derived mouse macrophages. Reproduced with permission from
the American Chemical Society.41 (e) Chemical structure of YBN14, a cathepsin specific activity-based theranostic agent. (f) 4T1 cancer cells were
injected subcutaneously into two separate locations on the back of BALB/c mice. After tumours were established (marked by black arrows), YBN14 was
injected intravenously and whole-body in vivo imaging was performed. After injecting YBN14 and start acquiring the first images, the right tumour was
treated with light at 8 and 16 h (indicated with thunder cartoons) while the left tumour was kept in the dark, which resulted in a significant decrease of
cathepsin activity. Reproduced with permission from Ivyspring.43
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recently employed in endoscopic imaging of the colon to visualise
early lesions that remained undetectable by conventional colono-
scopy. Early detection of colonic polyps can prevent most of
colorectal cancer deaths; however, there is a need for imaging
contrast agents that can improve current diagnostic methods.
Bogyo et al. recently described the application of one of their near-
infrared ABPs for enhanced detection of colorectal lesions using
fluorescence-guided colonoscopy.42 Notably, the administration
(either intravenously or intrarectally) of the quenched ABP probe
strongly labelled tumour-associated inflammatory cells (mostly
macrophages) within 1 h, rapidly discriminating polyps from
healthy areas both in mice and human tissue. Altogether, these
probes represent an important advancement for targeted colono-
scopy and may help in the identification of at-risk patients as well
as to improve the outcome of surgical interventions.
ABPs have been also adapted for theranostics (i.e. agents
combining imaging and therapeutic capabilities). The group of
Blum has recently developed new quenched ABPs incorporating
bacteriochlorin derivatives as both fluorophores and photo-
sensitizers (PS-qABPs, Fig. 4).43 These novel chemical structures
not only enabled imaging of cathepsin activity in tumour-
associated macrophages in vivo but also assessing the effects
of selective macrophage ablation using photodynamic therapy
(PDT). PDT relies on the irradiation of photosensitive molecules
in the presence of oxygen to produce singlet oxygen and ROS that
cause cell death. The targeted properties and irreversible binding
of PS-qABP resulted in the release and accumulation of photo-
sensitizers in tumour-associated macrophages after cathepsin
cleavage. Further activation by treatment with light induced
significant tumour shrinkage in an aggressive breast cancer
mouse model. Blum’s design overcomes some important limita-
tions of conventional PDT agents, such as (1) off-target cytotoxi-
city, which is reduced since the photosensitizer is only activated
in cells with high cathepsin activity, and (2) rapid clearance,
which is overcome by the covalent binding of PS-qABP to the
catalytic site of cathepsins. The combination of macrophage-
specific theranostic probes with translational modalities for
imaging and drug activation will open a new era for the study
and treatment of macrophage-related disorders.
4. Alternative fluorescence
amplification mechanisms for imaging
macrophages: diversity-oriented
fluorescence libraries
In the last few years, there has been an emerging interest in the
preparation of diversity-oriented fluorescence libraries as
an alternative strategy for the discovery of highly selective
fluorescent probes. Diversity-oriented fluorescence libraries
make use of combinatorial chemistry to produce large collec-
tions of small molecules with the potential to elicit an enhanced
fluorescence response upon binding to a defined target
(e.g. metabolites, proteins, cells, tissues).4 One of the main
advantages of these libraries is their compatibility with a broad
range of targets (from small molecules to cells) even when no
prior molecular knowledge is available, making it an ideal
approach for the discovery of probes to discriminate between
closely related cell states or phenotypes (e.g. resident vs. recruited
macrophages, M1 vs. M2 polarised-macrophages). Furthermore,
when a new probe is identified, it does not need to be further
modified as it already incorporates both binding and reporting
motifs. On the other hand, diversity-oriented fluorescence
libraries require the generation of vast collections of compounds
with broad chemical diversity and highly efficient imaging
screens to successfully discover new smart fluorophores.
Chang et al. has pioneered the use of diversity-oriented
fluorescence libraries for numerous applications. His group
recently reported this strategy to discover microglia-specific
fluorophores.44 Microglia are glial cells that represent the
first line of immune defense in the central nervous system,
behaving as the resident macrophages in the brain and spinal
cord tissues. The activity of microglia is conventionally imaged
using antibodies, which are limited in the acquisition of
dynamic information as well as in cell permeability. In this
work, the authors screened over 5000 small molecule fluoro-
phores in the BV2 microglia cell line by high-throughput cell
imaging to discover two BODIPY compounds with preferential
uptake in microglia over other glial cells and minimal impact in
their native function (Fig. 5). Further studies suggested mito-
chondrial protein cytochrome c oxidase subunit 2 as one of
their potential intracellular targets. These cell permeable smart
probes are powerful tools for monitoring microglia activity in
real time and in culture conditions that are only compatible
with live cell imaging (Movie S5 (ESI†)).
An important advantage of diversity-oriented fluorescence
libraries is their adaptability to most fluorophores, which allows
to diversify chemical structures with specific spectral properties.
This has been the case for the near-infrared tricarbocyanine
core, which was adapted to a diversity-oriented approach to
discover macrophage probes for in vivo imaging using FMT
and multispectral optoacoustic tomography (MSOT).45 From an
initial screen of around 200 near-infrared compounds, one probe
(CDnir7) was selected for its preferential uptake in macrophages
over other immune cells. Subsequent experiments validated the
application of CDnir7 for in vivo imaging of macrophage influx
in a mouse model of inflammation using FMT as well as MSOT
(Fig. 5). CDnir7 showed good properties as a translational
imaging agent, with rapid clearance (i.e. plasma half-life: 21 min)
and a much faster response (less than 10 min) than most
nanoparticle-based contrast imaging agents. Further studies have
been directed towards the optimisation of macrophage-specific
near-infrared fluorophores.46 A high-throughput flow cytometry
screening was designed to examine near-infrared fluorophores
in different human immune cell lines: MOLT-4 for lymphocytes,
U-937 for monocytes, and U-937-DM for monocyte-derived
macrophages. From a stringent primary cell-based imaging
screen, one hit compound (MF800) was validated in vivo to
visualise macrophage-rich areas of inflamed tissue. The
authors also performed intravital imaging experiments in
Csfr1-EGFP mice, where high correlation was observed between
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the signals of the transgenic green fluorescent macrophages
and the fluorescence emission of MF800 (Fig. 5). Immunofluor-
escence characterisation of the MF800-labelled cells confirmed
the expression of two macrophage surface markers (i.e. CD68
and CD169), which asserts the high selectivity of the MF800
architecture for macrophages.
The excellent safety profile (i.e. low toxicity, rapid clearance)
of small molecule fluorescent architectures makes them optimal
candidates for clinical translation as contrast agents in image-
guided surgery. Intraoperative imaging allows to visualise areas
of interest while the patient is undergoing surgery, helping the
surgeon to keep healthy tissue undamaged. One important
application of intraoperative imaging regards the identification
and staging of sentinel lymph nodes, which can be reached by
cancer cells from primary tumours in the early stages of meta-
static disease. Most optical probes for lymph node visualisation
Fig. 5 Diversity-oriented fluorescence libraries for the discovery of new macrophage-specific fluorophores. (A) a. Chemical structure of the microglia-
specific probe CDr10b. b. Fluorescence microscopy images of GFP-expressing microglia from CX3CR1-GFP transgenic mice. Cells were stained with
500 nM of CDr10b (red) and Hoechst 33342 for nuclear counterstaining (blue). Scale bar: 10 mm. c. Flow cytometry analysis confirmed that CDr10b stained
the GFP+ fraction of CX3CR1-GFP primary neural cells. Reproduced from ref. 44 with permission from The Royal Society of Chemistry. (B) a. Chemical
structure of the macrophage-specific probe CDnir7. b. Whole-body in vivo imaging and CDnir7 detection in LPS-induced inflamed regions of mouse paws.
c. Immunostaining analysis of CDnir7 (red) and the macrophage marker CD11b (green) from control tissue (top) and inflamed tissue (bottom). Scale bar:
50 mm. Reproduced from ref. 45 with permission from The Royal Society of Chemistry. (C) a. Chemical structure of the probe MF800. b. (top) Intravital
fluorescence imaging along the femoral artery displays MF800-labeled cells (red), which co-localise with the genetically-labelled macrophages (green) in
Csf1r-EGFP mice. Scale bars: 200 mm; (bottom) regions of collateral arteries with arteriogenesis show prominent cellular infiltration of MF800 + Csf1r + cells
(white arrows), indicative of arterial growth and repair by macrophages. Scale bars: 1000 mm. Reproduced from PLOS One.46
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rely on non-specific fluorophores that accumulate in the nodes
because of their hydrodynamic range. Chang et al. devised a
new intraoperative technology for lymph node staging based on
macrophage-specific fluorophores.47 Since these smart probes
showed a preferential uptake in macrophages compared to
other cells in the constituting nodes, high fluorescence signals
were observed in macrophage-rich lymph nodes with no or very
minor metastasis while low signals were detected in nodes
that had been replaced by cancer cells. This indirect readout
represents a new strategy for enhanced surgical guidance and
in situ detection of metastasis in lymph nodes.
5. Conclusions and outlook
5.1 Towards translational imaging
Recent advances in medical imaging have opened the possibility
to monitor the progression of disease in patients in real time and
with minimal invasiveness. The integration of smart fluorescent
probes for macrophages into translational imaging technologies
will provide a powerful experimental tool to revolutionise our
understanding on the roles that macrophages play in vivo.
Remarkable developments have been achieved in endoscope-
based imaging modalities, which enable direct access to deep
tissues (e.g. gastrointestinal tract, colon, lungs, among others)
for high-resolution imaging. A recent example was reported by
Lesur et al. with the application of smart fluorophores to
monitor the myeloperoxidase (MPO) activity of macrophages in
rats with acute lung injury using in vivo endoscopic confocal
fluorescence microscopy.48 The authors exploited the applica-
tion of SNAPF – a red-emitting fluorophore upon reaction with
the HOCl generated by MPO (see Section 2.1) – in intravital
endoscopic microscopy to visualise alveolar macrophages in the
inflamed lungs of rats. While further optimisation studies will be
necessary to ensure the compatibility and biodistribution of
smart fluorescent architectures in human tissue, these studies
represent a first step towards non-invasive ‘virtual’ biopsies as
point-of-care diagnostic tools. We anticipate that smart fluores-
cent probes for macrophages will also enhance the diagnostic
resolution of other clinical imaging modalities, such as optical
coherence tomography (OCT), to visualise atherosclerotic
plaques in coronary arteries. Smart fluorescent probes able to
discriminate between different states of macrophages will become
excellent tools to improve the diagnosis and prognosis of cardio-
vascular diseases and cancer, wherein prevalence of NO-producing
macrophages over other tumour-associated macrophages is
predictive of survival of colorectal cancer.
Medical imaging has also remarkably progressed in intra-
operative modalities to assist surgeons in the operating room.
These technologies reduce the risk of damaging critical organs or
removing healthy tissue, and they can provide in situ confirmation
that surgery was successful when tissue resection was involved.
Some of the above described smart probes for imaging tumour-
associated macrophages31 as well as lymph nodes47 have huge
potential for intraoperative imaging to enhance the outcomes
of cancer surgery. The recent report of Bogyo et al. employing
cathepsin substrate-based probes with the FDA-approved da
Vinci surgical system for fluorescence-guided tumour resection
illustrates the compatibility and potential of smart fluorescent
probes to help surgeons make rapid decisions in the operating
room when dealing with macrophage-related lesions (e.g. cancer,
inflammation).49
5.2 Not just a pretty image
Given the relevance of macrophage activity in many pathological
disorders, smart fluorescent probes targeting macrophages will
also play an important role in the emerging field of theranostics.
The recent work of Blum et al. with cathepsin-triggered quenched
photosensitizers is an excellent example of how these chemical
architectures can be integrated for both imaging and therapeutic
purposes.43 Such theranostic tools will have enormous impact in
the field of cancer, where there is clinical and experimental
evidence of the protumourigenic activity of tumour-associated
macrophages, although many other inflammatory disorders may
also benefit from therapies for selective macrophage ablation.
Future generations of smart theranostic agents may not only rely on
fluorophore/photosensitizers as imaging/therapeutic agents but
also incorporate prodrugs to be specifically released by defined
macrophage triggers (e.g. MMP or cathepsin cleavage, gradients of
pH, ROS). These tools will be optimal for clinical translation, with
enhanced cellular selectivity and potentially less side effects, as
well as minimal dependence on photoactivation, which could
become a limitation when accessing deep tissues.
The emerging rise of nanomaterials (e.g. nanoparticles,
polymers) will play an important role in the development
of better diagnostic and therapeutic tools.2 For instance,
novel biomaterials might be employed as nanotherapeutics to
modulate macrophage activity in vivo. Bratlie et al. recently
showed the potential of polymer chemistry to alter macrophage
polarisation.50 With a library of poly-(N-isopropylacrylamide-co-
acrylic acid) nanoparticles including different functional groups,
the authors developed a quantitative structure–activity relation-
ship method to determine the macrophage phenotypic response
to specific biomaterials. While these studies will require further
chemical collections to explore the vast array of macrophage
functions, the incorporation of smart fluorophores into respon-
sive biomaterials will create new exciting avenues to study
macrophage polarisation in vivo.
5.3 Fine-tuning the fluorescent ‘bullet’
Addressing the phenotype complexity is one of the biggest
challenges for those aiming at imaging macrophage activity
in vivo. Recent studies using large transcriptomic analysis suggest
that traditional classifications of macrophage cell states (e.g. M1/M2)
may not correlate in vivo. Macrophages are very plastic cells,
changing their functions in response to their microenvironment,
with even marked differences between individual cells. From the
chemical point of view, this means that future generations
of smart fluorescent probes will have to exploit not only the
differences between macrophages and other immune cell types
(e.g. neutrophils, lymphocytes) but also between different sub-
populations of macrophages. Potential strategies may involve the
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incorporation of ligands targeting subcellular organelles for
additional selectivity. For instance, Chang et al. compared the
behaviour of their HOCl-reactive fluorophores in the lysosomes
and mitochondria of macrophages by simply conjugating
morpholine (for lysosomes) and triphenylphosphine (for mito-
chondria) moieties to the fluorophore counterpart.20 Alternative
strategies may involve the derivatization of reactive fluorophores
with high affinity ligands (e.g. O(6)-benzylguanine derivatives for
SNAP-tag proteins) to localise the smart probes in specific cells
or subcellular regions.8 Peptides are a good source of targeting
ligands, and they have been widely used to increase the cellular
selectivity of small molecules and drugs. The integration of
peptide sequences within smart fluorescent probes may become
an interesting strategy for the development of highly selective
imaging agents aiming at specific functions/states of macro-
phages. However, it is also possible that multiple ligands and/or
activation triggers are necessary to target specific subpopula-
tions of macrophages. This concept was nicely illustrated by
Umezawa et al., who developed genetically-encoded reporters
exploiting the synergistic activation by scavenger receptor class A
type I and MMP-9 (i.e. key biomarkers for the progression of
atherosclerosis) to discriminate between activated and resting
macrophages.33 In the next few years, organic chemists and
chemical biologists are facing the challenge of constructing
translatable smart fluorescent probes that can achieve such high
levels of specificity.
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